CINECA IRIS Institutional Research Information System

CASSANO, GIOVANNI BATTISTA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 15.914
AS - Asia 5.742
EU - Europa 4.802
SA - Sud America 799
AF - Africa 249
Continente sconosciuto - Info sul continente non disponibili 147
OC - Oceania 21
Totale 27.674
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 15.407
SG - Singapore 1.782
CN - Cina 1.625
IT - Italia 1.476
HK - Hong Kong 990
SE - Svezia 703
BR - Brasile 678
DE - Germania 582
BG - Bulgaria 456
VN - Vietnam 387
CA - Canada 383
TR - Turchia 364
UA - Ucraina 270
GB - Regno Unito 267
FI - Finlandia 264
FR - Francia 237
RU - Federazione Russa 203
KR - Corea 155
CH - Svizzera 141
IN - India 110
SN - Senegal 107
JP - Giappone 51
BD - Bangladesh 49
CI - Costa d'Avorio 44
IQ - Iraq 41
BE - Belgio 33
MX - Messico 32
NL - Olanda 30
SA - Arabia Saudita 29
ZA - Sudafrica 27
AR - Argentina 26
GR - Grecia 26
JM - Giamaica 23
ES - Italia 22
PK - Pakistan 19
VE - Venezuela 19
CO - Colombia 18
ID - Indonesia 18
AT - Austria 17
AU - Australia 17
EC - Ecuador 17
CR - Costa Rica 16
PL - Polonia 15
KE - Kenya 14
EG - Egitto 13
CL - Cile 11
MY - Malesia 11
MA - Marocco 10
PH - Filippine 10
IR - Iran 9
NP - Nepal 9
AZ - Azerbaigian 8
HN - Honduras 8
IE - Irlanda 8
RS - Serbia 8
UZ - Uzbekistan 8
BO - Bolivia 7
GT - Guatemala 7
IL - Israele 7
JO - Giordania 7
NI - Nicaragua 7
OM - Oman 7
PE - Perù 7
PY - Paraguay 7
UY - Uruguay 7
BJ - Benin 6
KZ - Kazakistan 6
TN - Tunisia 6
BB - Barbados 5
DZ - Algeria 5
ET - Etiopia 5
LB - Libano 5
NG - Nigeria 5
PA - Panama 5
PT - Portogallo 5
RO - Romania 5
TT - Trinidad e Tobago 5
AE - Emirati Arabi Uniti 4
AM - Armenia 4
LT - Lituania 4
MD - Moldavia 4
NZ - Nuova Zelanda 4
PS - Palestinian Territory 4
SV - El Salvador 4
AL - Albania 3
BA - Bosnia-Erzegovina 3
BY - Bielorussia 3
CZ - Repubblica Ceca 3
DK - Danimarca 3
DO - Repubblica Dominicana 3
NO - Norvegia 3
PR - Porto Rico 3
TH - Thailandia 3
BH - Bahrain 2
BN - Brunei Darussalam 2
BS - Bahamas 2
GE - Georgia 2
GH - Ghana 2
HR - Croazia 2
HU - Ungheria 2
Totale 27.498
Salva come PNG Salva come JPEG
Città #
Woodbridge 1.868
Ashburn 1.562
Fairfield 1.221
Ann Arbor 1.125
Singapore 1.031
Hong Kong 972
Houston 941
Chandler 827
Santa Clara 684
Milan 652
San Jose 609
Seattle 493
Sofia 456
Dallas 452
Cambridge 436
Wilmington 430
Jacksonville 382
Shanghai 340
New York 334
Beijing 318
Ottawa 294
Izmir 274
Council Bluffs 271
Nanjing 196
Boardman 189
Hefei 186
Princeton 177
Lawrence 172
Medford 170
Frankfurt am Main 165
Los Angeles 160
Seoul 151
Lauterbourg 148
Bern 123
Dakar 107
Des Moines 88
Chicago 81
Dearborn 79
Nanchang 74
Ho Chi Minh City 73
Buffalo 72
Hanoi 70
Istanbul 68
São Paulo 67
Jüchen 66
Rome 66
Helsinki 58
Redondo Beach 56
Columbus 50
Dong Ket 50
Florence 49
London 49
San Diego 49
The Dalles 49
Serra 48
Munich 45
Abidjan 44
Falls Church 44
Tokyo 41
Redwood City 39
Washington 39
Boulder 35
Phoenix 33
Brussels 32
Turku 32
Hebei 31
Kunming 31
San Francisco 31
Toronto 31
Bremen 30
Marseille 29
Belo Horizonte 28
Ogden 28
Brooklyn 27
Norwalk 27
Tianjin 27
Denver 26
Shenyang 26
Lancaster 25
Pune 23
Changsha 22
Hangzhou 19
Jiaxing 19
Rio de Janeiro 19
Orem 18
Zurich 18
Montreal 15
Pisa 14
San José 14
Vienna 14
Atlanta 13
Chennai 13
Da Nang 13
Detroit 13
Dhaka 13
Fuzhou 13
Orange 13
Baghdad 12
Curitiba 12
Jeddah 12
Totale 20.281
Salva come PNG Salva come JPEG
Nome #
SENSITIVITY TO CHANGE AND PREDICTIVE VALIDITY OF THE MOODS-SR QUESTIONNAIRE, LAST-MONTH VERSION 458
The relationships among separation anxiety disorder, adult attachment style and agoraphobia in patients with panic disorder 322
The role of newer antiglutamatergic agents as mood-stabilizers in bipolar disorder 321
Psychotic features in borderline patients: is there a connection to mood dysregulation? 316
[H-3]-ketanserin binding sites in different psychiatric disorders 289
Reasons for substance use and vulnerability factors in patients with substance use disorder and anxiety or mood disorders 279
Validity and reliability of the Structured Clinical Interview for the Trauma and Loss Spectrum (SCI-TALS). 254
Psychological and psychiatrical assessment in obese patients undergoing bariatric surgery 239
Axis I and II disorders and quality of life in bariatric surgery candidates 228
Clinical characteristics and treatment outcome of depression in patients with and without a history of emotional and physical abuse 227
Development and preliminary testing of the General 5-Spectrum Measure (GSM-V) 220
VALORE PREDITTIVO DI VARIABILI PSICOPATOLOGICHE E LORO MODIFICHE DOPO DECREMENTO PONDERALE OTTENUTO MEDIANTE INTERVENTO DI BENDAGGIO GASTRICO REGOLABILE 215
Psychiatric disorders and lifetime Mood Spectrum Symptoms in Early and Late Onset Obesity 214
CONFRONTO TRA DIVERSI STRUMENTI DI VALUTAZIONE PSICOPATOLOGICA IN PAZIENTI GRANDI OBESI CANDIDATI A CHIRURGIA BARIATRICA 213
Frequency and clinical correlates of adult separation anxiety in a sample of 508 outpatients with mood and anxiety disorders 210
A multidimensional spectrum approach to post-traumatic stress disorder: comparison between the Structured Clinical Interview for Trauma and Loss Spectrum (SCI-TALS) and the Self-Report instrument (TALS-SR). 210
Exploration of the clinical profile of rubidium chloride in depression: a systematic open trial 205
Psychotic and nonpsychotic bipolar mixed states: comparisons with manic and schizoaffective disorders 205
Clinical correlates of depersonalization symptoms in patients with bipolar disorder 205
Catechol O-methyltransferase, serotonin transporter, and tryptophan hydroxylase gene polymorphisms in bipolar disorder patients with and without comorbid panic disorder 204
Platelet sulfotransferase in different psychiatric disorders 203
The spectrum of substance abuse in bipolar disorder: reasons for use, sensation seeking and substance sensitivity 203
A spectrum model for mood disorders: a useful approach in clinical psychiatry in search of an assessment methodology 202
Prevalence of anxiety disorders comorbidity in bipolar depression, unipolar depression and dysthymia 201
Venlafaxine in somatopsychic and autopsychic depersonalization. 201
The Spontaneous Ala147Thr Amino Acid Substitution within the Translocator Protein Influences Pregnenolone Production in Lymphomonocytes of Healthy Individuals 201
Ala147Thrsubstitution in translocator protein is associated with adult separation anxiety in patients with depression 200
Validity and reliability of the Structured Clinical Interview for Obsessive-Compulsive Spectrum (SCI-OBS) and of the Structured Clinical Interview for Social Phobia Spectrum (SCI-SHY) 198
Ligandi endogeni per i recettori delle benzodiazepine: nuovo approccio allo studio della biologia dell’ansia. 195
Addressing the challenges of a cross-national investigation: lessons from the Pittsburgh-Pisa study of treatment-relevant phenotypes of unipolar depression 193
Mutation analysis of oxytocin gene in individuals with adult separation anxiety 192
Psycological variables as potential predictors of successful outcomes for weight loss programs followings Swedish adjustable gastric banding 191
Clinical characteristics of mania, mixed mania, and bipolar depression with psychotic features. 188
Catechol-O-methyltransferase Val158Met polymorphism in schizophrenia: associations with cognitive and motor impairment 187
Measuring Mood spectrum: comparison of interview (SCI-MOODS) and self-report (MOODS-SR)instruments 187
Insight into illness in schizophrenia, schizoaffective disorder and mood disorders with psychotic features 187
THE SPECTRUM OF SUBSTANCE USE IN MOOD AND ANXIETY DISORDERS 187
Predictors of response among patients with panic disorder treated with medications in a naturalistic follow-up: the role of adult separation anxiety. 187
The role of quetiapine in the treatment of bipolar disorder 186
Distinguishing affective depersonalization from anhedonia in major depression and bipolar disorder 186
Beyond "postpartum depressions": Specific anxiety diagnoses during pregnancy predict different outcomes Results from PND-ReScU 185
Borderline personality disorder and mood spectrum 185
Oxcarbazepine as add-onn treatment in patients with bipolar manic, mixed or depressive episode 185
TREATMENT EMERGENT MANIA/HYPOMANIA IN UNIPOLAR PATIENTS 184
Neurocognitive functioning in bulimia nervosa: the role of neuroendocrine, personality and clinical aspects 184
PRAMIPEXOLE IN TREATMENT-RESISTANT DEPRESSION: AN EXTENDED FOLLOW-UP 183
Olanzapine versus lithium in the maintenance treatment of bipolar disorder: a 12-month, randomized, double-blind, controlled clinical trial. 183
THE NEUROBIOLOGY AND CLINICAL SIGNIFICANCE OF DEPERSONALIZATION IN MOOD AND ANXIETY DISORDERS: A CRITICAL REAPPRAISAL 182
Lifetime rhythmicity and mania as correlates of suicidal ideation and attempts in mood disorders. 182
Acceptability, validity and reliability of the Structured Clinical Interview for the Spectrum of Substance Use (SCI-SUBS): a pilot study 181
Comparative response to electroconvulsive therapy in medication-resistant bipolar I patietns with depression and mixed state 180
Asymptomatic hypermylasemia and hyperlipasemia associated with aripiprazole 177
Phenotypic effects of a bipolar liability gene among individuals with major depressive disorder 173
Occurrence and clinical correlates of psychiatric comorbidity in patients with psychotic disorders 173
The mood spectrum in unipolar and bipolar disorder: arguments for a unitary approach. 173
EFFICACY AND SAFETY OF AMISULPRIDE 50 MG VERSUS PAROXETINE 20 MG IN MAJOR DEPRESSION: A RANDOMIZED, DOUBLE-BLIND, PARALLEL GROUP STUDY 172
The factor structure of lifetime depressive spectrum in patients with unipolar depression 172
CATECHOL-O-METHYLTRANSFERASE GENE VARIANTS IN MOOD DISORDERS IN THE ITALIAN POPULATION 171
Frequency and clinical correlates of adult separation anxiety in a sample of 508 outpatients with mood and anxiety disorders 171
Oxytocin receptor polymorphisms and adult attachment style in patients with depression 171
Prevalence and burdern of bipolar disorders in Europe 170
Citalopram in refractory obsessive-compulsive disorder: an open study 170
Social anxiety spectrum: Gender differences in Italian high school students 169
THE STRUCTURE OF LIFETIME MANIC-HYPOMANIC SPECTRUM 167
Efficacy of ECT in depression: a meta-analytic review 167
Rating scales for the assessment of depersonalization symptoms: a review 166
The role of psychomotor activation in discriminating unipolar from bipolar disorders: a classification-tree analysis. 166
Asymptomatic hyperamylasemia and hyperlipasemia associated with aripiprazole 166
THE PANIC-AGORAPHOBIC SPECTRUM: DEVELOPMENT, DESCRIPTION AND CLINICAL SIGNIFICANCE 165
Intravenous citalopram in resistant OCD 165
Social Anxiety disorder comorbidity in patients with bipolar disorder: a clinical replication 165
Pramipexole in treatment-resistant depression: a 16-week naturalistic study 165
No correlation between aggression and platelet (3)H-paroxetine binding in obsessive-compulsive disorder patients. 165
AWARENESS OF DISORDER AND SUICIDE RISK IN THE TREATMENT OF SCHIZOPHRENIA: RESULTS OF THE INTERNATIONAL SUICIDE PREVENTION TRIAL 165
Evaluation of disease awareness in a sample of patients with eating disorder: a preliminary study 164
Oxytocin receptor polymorphisms and adult attachment style in patients with depression 164
Axis I comorbidity in bipolar disorder with psychotic features 162
Correlation between spectrum symptomatology and personality disorders in patients affected by overweight or obesity 161
FAMILY HISTORY OF PSYCHIATRIC DISORDERS AND ALCOHOL AND SUBSTANCE MISUSE IN PATIENTS WITH BIPOLAR I DISORDERS, SUBSTANCE USE DISORDER OR BOTH 161
PSYCOPATHOLOGICAL ASSESSMENT OF A SAMPLE OF PATIENTS CANDIDATES FOR TRANSPLANTATION 161
Patterns of structural MRI abnormalities in deficit and nondeficit schizophrenia 161
PREVALENCE AND BURDEN OF BIPOLAR DISORDERS IN EUROPEAN COUNTRIES 160
Electroconvulsive therapy in medication-nonresponsive patients with mixed mania and bipolar depression 159
Mutation analysis of oxytocin gene in individuals with adult separation anxiety 159
HEALTH-RELATED QUALITY OF LIFE IN EUTHYMIC BIPOLAR DISORDER PATIENTS: DIFFERENCES BETWEEN BIPOLAR I AND II SUBTYPES 158
Effect of age, weight and CYP2C19 genotype on escitalopram exposure 157
internal consistency and discriminant validity of a new instrument for assessing mood symptomatology: the structured clinical interview for mood spectrum (SCI-MOODS) 157
Treatment of depression with comorbid anxiety disorders: differential efficacy of paroxetine versus moclobemide 157
The bipolar spectrum: a clinical reality in search of diagnostic criteria and an assessment methodology 157
LO SPETTRO ANORESSICO-BULIMICO NEI DISTURBI DELLA CONDOTTA ALIMENTARE, DELL’UMORE E NEI CONTROLLI SANI 155
Spettro dell'umore in gravidanza e nel postpartum 155
Measuring social anxiety and obsessive-compulsive spectra: comparison of interviews and self-report instruments. 155
The psychotic spectrum: validity and reliability of the Structured Clinical Interview for the Psychotic Spectrum. 155
Serotonin-mediated cyclic AMP inhibitory pathway in platelets of patients affected by panic disorder 155
MULTIDIMENSIONAL ASSESSMENT OF THE PANIC-AGORAPHOBIC SPECTRUM: RELIABILITY AND VALIDITY OF THE SPANISH VERSION OF THE PAS-SR 153
Substance use in severe mental illness: self-medication and vulnerability factors 152
Sensitivity to change and predictive validity of the MOODS-SR questionnaire, last-month version 152
Validity and reliability of a new instrument for assessing mood symptomatology: the Structured Clinical Interview for Mood Spectrum (SCI-MOODS) 152
The Mood Spectrum Self-Report: Validation and adaptation into Spanish 152
mRNA expression of serotonin receptors of type 2C and 5A in human resting lymphocytes., 152
Totale 18.893
Salva come PNG Salva come JPEG
Categoria #
all - tutte 71.420
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 71.420
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.727 0 0 28 126 389 261 47 99 107 77 99 494
2022/20232.328 301 225 117 227 262 274 15 171 586 13 119 18
2023/20242.045 316 281 271 161 315 330 28 42 25 56 32 188
2024/20254.922 27 184 20 255 487 477 493 307 480 667 507 1.018
2025/20264.626 337 633 435 250 456 480 755 218 182 381 434 65
2026/20271.403 104 586 713 0 0 0 0 0 0 0 0 0
Totale 27.674